128 related articles for article (PubMed ID: 2154784)
1. Respiratory effects of receptor-selective opioids in rhesus monkeys.
France CP; Woods JH
Prog Clin Biol Res; 1990; 328():295-8. PubMed ID: 2154784
[No Abstract] [Full Text] [Related]
2. Effects of levorphanol and several kappa-selective opioids on respiration and behavior in rhesus monkeys.
Howell LL; Bergman J; Morse WH
J Pharmacol Exp Ther; 1988 Apr; 245(1):364-72. PubMed ID: 2834543
[TBL] [Abstract][Full Text] [Related]
3. Apparent pA2 analysis on the respiratory depressant effects of alfentanil, etonitazene, ethylketocyclazocine (EKC) and Mr2033 in rhesus monkeys.
Butelman ER; France CP; Woods JH
J Pharmacol Exp Ther; 1993 Jan; 264(1):145-51. PubMed ID: 8093721
[TBL] [Abstract][Full Text] [Related]
4. Discriminative stimulus effects of mu and kappa opioids in the pigeon: analysis of the effects of full and partial mu and kappa agonists.
Picker MJ; Dykstra LA
J Pharmacol Exp Ther; 1989 May; 249(2):557-66. PubMed ID: 2566680
[TBL] [Abstract][Full Text] [Related]
5. Further study of kappa opioids on increased urination.
Leander JD
J Pharmacol Exp Ther; 1983 Oct; 227(1):35-41. PubMed ID: 6137557
[TBL] [Abstract][Full Text] [Related]
6. Comparison of kappa opioids in rhesus monkeys: behavioral effects and receptor binding affinities.
France CP; Medzihradsky F; Woods JH
J Pharmacol Exp Ther; 1994 Jan; 268(1):47-58. PubMed ID: 8301589
[TBL] [Abstract][Full Text] [Related]
7. Differential activity of selective opioid agonists on hypothalamic magnocellular neuronal activity.
Clarke G; Davison I; MacMillan SJ; Wright DM
Prog Clin Biol Res; 1990; 328():351-4. PubMed ID: 2154792
[No Abstract] [Full Text] [Related]
8. Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists.
Picker MJ; Doty P; Negus SS; Mattox SR; Dykstra LA
J Pharmacol Exp Ther; 1990 Jul; 254(1):13-22. PubMed ID: 2164087
[TBL] [Abstract][Full Text] [Related]
9. Kappa opiate receptor agonists: effects on behavior and on brain function and structure in rhesus monkeys.
Heath RG; Fitzjarrell AT; Walker CF
Biol Psychiatry; 1984 Jul; 19(7):1045-74. PubMed ID: 6089918
[TBL] [Abstract][Full Text] [Related]
10. Selective kappa opioid agonist for spinal analgesia without the risk of respiratory depression.
Castillo R; Kissin I; Bradley EL
Anesth Analg; 1986 Apr; 65(4):350-4. PubMed ID: 3006552
[TBL] [Abstract][Full Text] [Related]
11. Butorphanol: characterization of agonist and antagonist effects in rhesus monkeys.
Butelman ER; Winger G; Zernig G; Woods JH
J Pharmacol Exp Ther; 1995 Feb; 272(2):845-53. PubMed ID: 7853203
[TBL] [Abstract][Full Text] [Related]
12. U-50,488: a selective and structurally novel non-Mu (kappa) opioid agonist.
Vonvoigtlander PF; Lahti RA; Ludens JH
J Pharmacol Exp Ther; 1983 Jan; 224(1):7-12. PubMed ID: 6129321
[TBL] [Abstract][Full Text] [Related]
13. Effects of kappa opioids on schedule-controlled behavior of squirrel monkeys.
Bergman J; Warren PH
J Pharmacol Exp Ther; 1989 Mar; 248(3):1102-8. PubMed ID: 2539457
[TBL] [Abstract][Full Text] [Related]
14. Effects of kappa-opioid receptor agonists on locomotor activity and memory processes in mice.
Castellano C; Ammassari-Teule M; Libri V; Pavone F
Pol J Pharmacol Pharm; 1988; 40(5):507-13. PubMed ID: 2855367
[TBL] [Abstract][Full Text] [Related]
15. Similar actions of kappa and mu agonists on spinal nociceptive reflexes in rats and their reversibility by naloxone.
Parsons CG; West DC; Headley PM
NIDA Res Monogr; 1986; 75():461-4. PubMed ID: 2828992
[TBL] [Abstract][Full Text] [Related]
16. A new analysis of whole-body calorimetry data.
Lynch TJ; Martinez RP; Furman MB; Geller EB; Adler MW
NIDA Res Monogr; 1989; 95():289-90. PubMed ID: 2561834
[No Abstract] [Full Text] [Related]
17. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.
Porreca F; Mosberg HI; Hurst R; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1984 Aug; 230(2):341-8. PubMed ID: 6086883
[TBL] [Abstract][Full Text] [Related]
18. Cross-tolerance between mu- and kappa-opioid agonists in the guinea pig ileum myenteric plexus.
Garaulet JV; Laorden ML; Milanés MV
J Pharmacol Exp Ther; 1994 Jun; 269(3):993-9. PubMed ID: 8014886
[TBL] [Abstract][Full Text] [Related]
19. Mu- and delta-opioid receptor-mediated inhibition of adenylate cyclase activity stimulated by released endogenous dopamine in rat neostriatal slices; demonstration of potent delta-agonist activity of bremazocine.
Heijna MH; Hogenboom F; Portoghese PS; Mulder AH; Schoffelmeer AN
J Pharmacol Exp Ther; 1989 Jun; 249(3):864-8. PubMed ID: 2543814
[TBL] [Abstract][Full Text] [Related]
20. Kappa opioids in rhesus monkeys. III. Dependence associated with chronic administration.
Gmerek DE; Dykstra LA; Woods JH
J Pharmacol Exp Ther; 1987 Aug; 242(2):428-36. PubMed ID: 3302208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
